翱捷科技首次公开发行股票募集资金总额为68.83亿元，扣除发行费用后募集资金净额为65.46亿 元。翱捷科技最终募集资金净额比原计划多41.66亿元。该公司于2022年1月10日披露的招股说明书显 示，其拟募集资金23.80亿元，拟分别用于新型通信芯片设计，智能IPC芯片设计项目，多种无线协议融 合、多场域下高精度导航定位整体解决方案及平台项目，研发中心建设项目，补充流动资金项目。 翱捷科技首次公开发行股票的发行费用总额为3.37亿元，其中，保荐及承销费用3.10亿元。 （责任编辑：魏京婷） 中国经济网北京10月10日讯 翱捷科技(688220.SH)今日收报98.50元，跌幅12.85%。目前该股处于破 发状态。 翱捷科技于2022年1月14日在上交所科创板上市，发行的股票数量为4183.0089万股，发行价格为 164.54元/股，保荐人（主承销商）为海通证券股份有限公司（现更名为国泰海通证券股份有限公 司），保荐代表人为王鹏程、龚思琪。 上市首日开盘即破发，翱捷科技盘中最高价报130.11元，为该股上市以来最高价。 ...

中国经济网北京10月10日讯宏力达(688330.SH)昨日晚间发布公告称，近日，公司收到公司董事、总经 理、核心技术人员冷春田和公司副总经理、核心技术人员赖安定分别出具的《关于减持股份计划的告知 函》。 冷春田、赖安定基于个人资金需求，计划自减持股份计划公告披露之日起15个交易日后的3个月内，通 过集中竞价交易方式减持宏力达股份。其中，冷春田拟通过集中竞价交易方式减持宏力达股份不超过 541,451股，占宏力达总股本的比例不超过0.39%；赖安定拟通过集中竞价交易方式减持宏力达股份不超 过1,400,000股，占宏力达总股本的比例不超过1%。 宏力达首次公开发行股票募集资金总额为22.06亿元，扣除发行费用后，募集资金净额为20.66亿元。宏 力达最终募集资金净额较原计划多8.66亿元。宏力达于2020年9月30日发布的招股说明书显示，该公司 计划募集资金12.00亿元，分别用于上海生产基地及研发中心和总部大楼建设项目、泉州生产基地建设 项目、补充流动资金。 宏力达首次公开发行股票的发行费用为1.39亿元，其中，保荐及承销费用1.24亿元。 2023年6月7日，宏力达发布的2022年年度权益分派实施公告显示 ...

以光庭信息10月9日收盘价54.01元计算，王军德计划减持套现金额约为432.08万元。 中国经济网北京10月10日讯 光庭信息（301221.SZ）昨晚发布关于公司董事、高级管理人员减持 股份的预披露公告。 本次拟减持的股东为公司董事、总经理王军德，目前直接持有公司346,500股，占公司总股本的 0.3741%，为公司首次公开发行前已发行股份。 王军德计划在公告披露之日起15个交易日后3个月内（即2025年11月3日至2026年2月2日）通过集 中竞价方式减持公司股份不超过80,000股（不超过公司总股本比例为0.0864%）。 减持原因为个人资金需求，减持价格区间：在遵守相关法律、法规和深圳证券交易所规则的前提 下，根据减持时二级市场价格确定。 股东王军德不是公司控股股东、实际控制人，本次股份减持计划不会对公司治理结构、股权结构及 未来持续经营产生重大影响，也不会导致公司控制权发生变更。 光庭信息于2021年12月22日在深交所创业板上市，公开发行数量为2315.56万股，发行价格为 69.89元/股，保荐机构（主承销商）为国金证券股份有限公司，保荐代表人为王展翔、赵简明。目前该 股处于破发状态。 光庭 ...

中国经济网北京10月9日讯禾赛科技（02525.HK）港股今日收报210.60港元，涨幅0.00%。禾赛科技今 日盘中最低至208.60港元，创上市以来新低。禾赛科技10月8日港股最低价210.00港元，收盘价210.60港 元，跌破港股发售价。 禾赛科技2025年9月16日在港交所上市。最终发售价及配发结果公告显示，禾赛科技全球发售项下的发 售股份数目为19,550,000股发售股份（经计及发售量调整权获悉数行使及视乎超额配股权行使与否而 定），香港发售股份数目为1,955,000股发售股份（经计及发售量调整权获悉数行使），国际发售股份数 目为17,595,000股发售股份（经计及发售量调整权获悉数行使及视乎超额配股权行使与否而定）。 禾赛科技的联席保荐人、保荐人兼整体协调人、整体协调人、联席全球协调人、联席账簿管理人及联席 牵头经办人为中国国际金融香港证券有限公司、国泰君安融资有限公司、招银国际融资有限公司，整体 协调人、联席全球协调人、联席账簿管理人及联席牵头经办人为海通国际证券有限公司、中银国际亚洲 有限公司，联席全球协调人、联席账簿管理人及联席牵头经办人为富途证券国际（香港）有限公司、星 展亚洲融资 ...

南新制药首次公开发行股票募集资金总额为12.23亿元，募集资金净额为11.35亿元，比原拟募集资 金多4.66亿元。南新制药2020年3月20日招股书显示，该公司原拟募集资金6.70亿元，分别用于创新药研 发项目、营销渠道网络升级建设项目、补充流动资金。 南新制药首次公开发行股票的发行费用总计为8761.77万元（不含增值税），其中，西部证券股份 有限公司获得保荐及承销费用合计7110.75万元（不含增值税）。 2022年7月16日，南新制药披露2021年年度权益分派实施公告，以方案实施前的公司总股本 140,000,000股为基数，以资本公积金向全体股东每股转增0.4股，共计转增56,000,000股，本次分配后总 股本为196,000,000股。股权登记日为2022年7月21日，除权（息）日为2022年7月22日。 2023年6月7日，公司披露2022年年度权益分派实施公告，以方案实施前的公司总股本196,000,000股 为基数，以资本公积金向全体股东每股转增0.4股，共计转增78,400,000股，本次分配后总股本为 274,400,000股。股权登记日为2023年6月12日，除权（息）日为2023年 ...

中国经济网北京9月18日讯华厦眼科（301267）(301267.SZ)今日股价下跌，截至收盘报20.72元，跌幅 2.95%。该股目前处于破发状态。 华厦眼科于2022年11月7日在深交所创业板上市，发行价格50.88元/股，保荐机构(主承销商)为中国国际 金融股份有限公司，保荐代表人为沈俊、赵冀。 华厦眼科首次公开发行股票募集资金总额为305,280.00万元，扣除发行费用(不含增值税)后，募集资金 净额为276,849.25万元。华厦眼科最终募集资金比原计划多198998.64万元。华厦眼科于2022年10月28日 披露的招股说明书显示，该公司原拟募资77,850.61万元，分别用于天津华厦眼科医院项目、区域视光中 心建设项目、现有医院医疗服务能力升级项目、信息化运营管理系统建设项目、补充运营资金项目。 华厦眼科首次公开发行股票的发行费用为28,430.75万元，其中保荐及承销费用为23,201.28万元。 2023年7月4日，华厦眼科披露2022年年度权益分派实施公告。以2022年12月31日的总股本56,000.00万股 为基数，向全体股东每10股派发现金红利人民币2.8元(含税)，共计派发现金红利 ...

Core Viewpoint - The financial performance of Gao Ling Information (688175.SH) in the first half of 2025 shows a revenue increase but significant net losses, indicating ongoing challenges in profitability despite revenue growth [1][3]. Financial Performance Summary - In the first half of 2025, the company achieved operating revenue of 95.20 million yuan, a year-on-year increase of 15.55% compared to 82.39 million yuan in the same period last year [1][3]. - The total profit for the period was -41.43 million yuan, representing a decline of 27.70% from -32.44 million yuan in the previous year [3]. - The net profit attributable to shareholders was -33.07 million yuan, a decrease of 46.99% from -22.50 million yuan year-on-year [3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -44.15 million yuan, showing a slight improvement of 2.90% compared to -45.46 million yuan in the previous year [3]. - The net cash flow from operating activities was -76.06 million yuan, an improvement of 8.51% from -83.13 million yuan in the same period last year [3]. Historical Financial Data - In 2024, the company reported an operating revenue of 266.48 million yuan, a decline of 25.23% from 356.39 million yuan in 2023 [3]. - The net profit attributable to shareholders in 2024 was -52.28 million yuan, a significant drop of 213.52% from 46.05 million yuan in 2023 [3]. - The net cash flow from operating activities in 2024 was -66.86 million yuan, a drastic decline of 200.68% from 66.41 million yuan in 2023 [3]. IPO and Fundraising - Gao Ling Information was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on March 15, 2022, with an initial share price of 51.68 yuan and a total fundraising amount of 1.20 billion yuan [4]. - The actual net fundraising amount was 1.11 billion yuan, which was 392 million yuan less than the originally planned amount of 1.50 billion yuan [4]. - The funds were intended for various projects, including upgrades to security communication systems and data application projects [4]. Dividend Distribution - In 2024, the company announced a cash dividend of 0.20 yuan per share and a capital reserve transfer of 0.40 shares for every share held, resulting in a total distribution of approximately 18.58 million yuan in cash dividends and an increase in total shares to 130.07 million [5].

Core Viewpoint - Suzhou Xieli Venture Capital Co., Ltd. plans to reduce its shareholding in Yinghua Technology (301272.SZ) by up to 581,693 shares, representing 1% of the total share capital after excluding shares in the company's repurchase account [1][2]. Group 1: Shareholding and Reduction Plan - Suzhou Xieli Venture Capital holds 5,069,200 shares, accounting for 8.71% of the total share capital after excluding shares in the company's repurchase account [1][3]. - The reduction will occur within three months after a 15 trading day period from the announcement date, using a centralized bidding method [1]. Group 2: Compliance and Regulations - The share reduction complies with regulations set forth in the Interim Measures for the Administration of Share Reduction by Shareholders of Listed Companies and other relevant guidelines [1]. - The investment period for Suzhou Xieli Venture Capital and its associated entity has exceeded 60 months, allowing for the reduction of shares without percentage restrictions [1]. Group 3: Financial Overview - Yinghua Technology's initial public offering (IPO) raised a total of 751.84 million yuan, with a net amount of 656.45 million yuan after deducting issuance costs [4]. - The company planned to use the raised funds for projects including the construction of a new production line for 500,000 units of scroll compressors and for working capital [4].

Group 1 - The core point of the news is that the major shareholder, Hongyun Jiukang Data Technology (Beijing) Co., Ltd., plans to reduce its stake in Jiahe Meikang by up to 1,375,855 shares, which is 1% of the total share capital, due to liquidity needs [1] - As of the announcement date, Hongyun Jiukang holds 8,485,931 shares, accounting for 6.17% of the total shares of Jiahe Meikang [1] - The shares to be sold were acquired before the company's initial public offering and have been tradable since December 14, 2022 [1] Group 2 - Jiahe Meikang raised a total of 1.362 billion yuan from its initial public offering, with a net amount of 1.24 billion yuan after deducting issuance costs [2] - The final net fundraising amount exceeded the original plan by 490 million yuan, which was initially set at 750 million yuan [2] - The funds raised are intended for various projects, including specialized electronic medical record development and data center upgrades [2]

Core Viewpoint - Renhe Intelligent (301129.SZ) announced a share reduction plan by its director and senior management, specifically by the financial director Chen Chaohui, who plans to reduce his holdings of 279,500 shares, accounting for 0.21% of the total share capital, within three months after the announcement [1] Group 1: Share Reduction Plan - Chen Chaohui holds 1,118,000 shares, approximately 0.82% of the total share capital, and intends to reduce his holdings through centralized bidding [1] - The shares to be reduced are from pre-IPO shares, shares from the restricted stock incentive plan, and shares obtained through capital reserve conversion [1] - The reduction will not lead to a change in control of the company or significantly impact its governance structure and future operations [1] Group 2: IPO and Fundraising - Renhe Intelligent raised a total of 1.025 billion yuan from its IPO, with a net amount of 917 million yuan after deducting issuance costs, exceeding the original plan by 518 million yuan [2] - The company initially planned to raise 399 million yuan for projects including the construction of a smart heating equipment production base and a research and testing center [2] Group 3: Financial Distribution - The issuance costs for the IPO amounted to 108 million yuan, with underwriting fees of 87.1469 million yuan [3] - In 2022, the company distributed a cash dividend of 8 yuan per 10 shares, totaling 59.512 million yuan, and also increased the share capital by 8 shares for every 10 shares held, resulting in a total of 59.512 million shares being distributed [3]